Mollan, MBChB, FRCOphth, PhD Honorary professor, University of Birmingham, EnglandConsultant neuro-ophthalmologist, University Hospitals Birmingham, England Disclosures: Mollan reports receiving grants or research income paid to her institution from National Institute of Health Research, UK Space Agency and Idiopathic Intracranial Hypertension UK
GLP-1 receptor activation slows gastric emptying, reduces appetite, and promotes satiety
Regular monitoring and dose regulation are therefore essential
Slower dose escalation reduces side effect intensity
Unlike intravenous administration, subcutaneous injections deliver medication into fatty tissue where any small air bubble is absorbed harmlessly by surrounding tissue
Oral options for GLP-1s are limited and initial data for DHT-GLP-1s promising, leading to the development of a series of studies that seek to find the best approach for a more convenient delivery method of this class of medicine